Drug Profile
Research programme: small molecule therapeutics - IM Therapeutics
Alternative Names: HLA programme - IM TherapeuticsLatest Information Update: 07 Nov 2022
Price :
$50
*
At a glance
- Originator
- Class Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders
Most Recent Events
- 05 Oct 2022 Early research for small molecule therapeutics is ongoing in the US
- 28 Sep 2022 No recent reports of development identified for research development in Autoimmune-disorders in USA
- 24 Sep 2020 Early research in Autoimmune disorders is ongoing in USA (IM Therapeutics pipeline, September 2020)